Alzheimer’s disease remains one of the most complex and devastating neurodegenerative disorders, affecting millions worldwide and placing an immense burden on patients, caregivers, and healthcare systems. Characterized by progressive cognitive decline, memory loss, and functional impairment, Alzheimer’s disease currently has no cure, making therapeutic innovation a critical priority. Traditional Alzheimer’s treatments have long focused on symptom management, primarily through cholinesterase inhibitors and NMDA receptor antagonists. However, these approaches offer only temporary relief without addressing the underlying causes of neurodegeneration.
In recent years, A...
